Argent BioPharma (ASX: RGT) Share Price

RGT

$0.038–+0.00%

$3.2MRank #1761 on ASXHealthcareDrug Manufacturers - Specialty & Generic

Prices updated 20 June 2026, 2:40 am AEST · Data: Financial Modeling Prep

Market Cap

$3.2M

Volume

2.3K

P/E Ratio

-0.39

EPS

-$0.0514

Dividend Yield

0.00%

52-Week High

$0.32

52-Week Low

$0.033

Beta

0.424

Argent BioPharma (ASX: RGT) is an Australian-listed company in the Healthcare sector with a market capitalisation of $3.2M and the 1761st-largest security on the ASX by market capitalisation. The RGT share price is $0.038, up 0.00% today and down 53.66% over the past 12 months. Shares have traded between $0.033 and $0.32 over the past 52 weeks. In its most recent reported period (ending 30 June 2025), Argent BioPharma reported revenue of $115,138 and a net loss of $3.7M.

Charts

$0.04

24H Range

$0.038

52-Week Range

$0.033

$0.32

About Argent BioPharma Limited

Argent BioPharma Limited, an Australian-headquartered biopharmaceutical firm founded in 2014, operates as a clinical-stage entity focused on developing innovative nano-engineered therapeutics. The company's core mission involves crafting treatments designed to re-establish a healthy balance between the nervous and immune systems, with its reach extending internationally to locations including Malta and Slovenia. Its diverse pipeline of product candidates is progressing through various clinical phases. CimetrA, a leading contender, is currently in Phase III trials targeting acute lung injury and Acute Respiratory Distress Syndrome (ARDS). For refractory epilepsy, CannEpil is undergoing Phase I clinical evaluation. Additionally, CogniCann is advancing through Phase IIA trials, aiming to offer symptomatic relief for Dementia and Alzheimer's disease. Beyond these clinical programs, Argent BioPharma is actively involved in the preclinical development of Irnican for Glioblastoma Multiforme and dedicates research and development efforts to wound treatment. The company has also forged a strategic partnership with SINTEF to enhance antimicrobial solutions for chronic wounds and explore potential applications in oncologic wound care. Previously known as MGC Pharmaceuticals Limited, the company officially rebranded to Argent BioPharma Limited.

IPO Date

24 Mar 2024

CEO

Roby Reuven Zomer

Website

argentbiopharma.com

Key Financial Data

Revenue (Quarterly)	$115,138
Net Income (Quarterly)	$-3.7M
Total Assets	$2.5M
Total Debt	$8.3M
Free Cash Flow	$-3.3M
Return on Equity	43.01%
Profit Margin	-3223.55%
Operating Margin	-4183.82%

RGT Frequently Asked Questions

What is the Argent BioPharma (ASX: RGT) share price?

The RGT share price is $0.038, up 0.00% for the day, based on the latest available ASX market data.

What is Argent BioPharma's market capitalisation?

Argent BioPharma has a market capitalisation of $3.2M, making it the 1761st-largest security listed on the ASX.

Does Argent BioPharma pay a dividend?

RGT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Argent BioPharma profitable?

In its most recent reported period (ending 30 June 2025), RGT reported revenue of $115,138 and a net loss of $3.7M.

How many RGT shares are on issue?

Argent BioPharma has approximately 84,969,105 shares on issue, based on its market capitalisation of $3.2M and current share price.

What sector is Argent BioPharma in?

Argent BioPharma is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Argent BioPharma list on the ASX?

Argent BioPharma listed on the Australian Securities Exchange on 24 Mar 2024.

Latest News

Transformative journey driving Argent BioPharma’s growth and US listing plans

Stockhead3 Sept 2025

Transformative journey driving Argent BioPharma’s growth and US listing plans Stockhead

Argent Biopharma Limited (ASX:RGT) - Shares, Dividends & News

intelligentinvestor.com.au2 Apr 2024

Argent Biopharma Limited (ASX:RGT) - Shares, Dividends & News intelligentinvestor.com.au

MGC Pharmaceuticals changing name to Argent BioPharma | LSE:MXC, OTC:RGTLF, ASX:RGT

Proactive financial news2 Apr 2024

MGC Pharmaceuticals changing name to Argent BioPharma | LSE:MXC, OTC:RGTLF, ASX:RGT Proactive financial news

Argent Biopharma Limited (ASX:RGT)

intelligentinvestor.com.au26 June 2024

Argent Biopharma Limited (ASX:RGT) intelligentinvestor.com.au

RGT Stock Price and Chart — ASX:RGT

TradingView3 Apr 2024

RGT Stock Price and Chart — ASX:RGT TradingView

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
ATXAmplia Therapeutics Limited	$59.0M	$0.115	-8.54	0.00%	▼-4.17%
RADRadiopharm Theranostics Limited	$47.3M	$0.02	-0.82	0.00%	–+0.00%
EZZEZZ Life Science Holdings Limited	$24.0M	$0.51	-25.86	1.35%	▲+0.99%
NTINeurotech International Limited	$15.2M	$0.015	-5.30	0.00%	▼-6.25%
PERPercheron Therapeutics Limited	$5.6M	$0.005	-0.79	0.00%	▲+11.11%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$55.71B	$116.32	▼-52.76%
RMDResMed Inc.	$38.70B	$26.68	▼-30.94%
SIGSigma Healthcare Limited	$31.86B	$2.76	▼-13.55%
FPHFisher & Paykel Healthcare Corporation Limited	$18.52B	$31.53	▼-6.24%
PMEPro Medicus Limited	$18.05B	$172.80	▼-38.98%
MPLMedibank Private Limited	$13.36B	$4.85	▲+0.72%
SHLSonic Healthcare Limited	$9.91B	$20.05	▼-23.60%
RHCRamsay Health Care Limited	$9.08B	$39.49	▲+8.93%
COHCochlear Limited	$7.73B	$118.14	▼-60.13%
TLXTelix Pharmaceuticals Limited	$4.91B	$14.50	▼-42.16%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
19 June 2026	$0.038	$0.038	$0.038	$0.038	2.3K	–+0.00%
18 June 2026	$0.035	$0.039	$0.035	$0.038	11K	▲+2.70%
17 June 2026	$0.035	$0.037	$0.035	$0.037	101	–+0.00%
16 June 2026	$0.035	$0.037	$0.035	$0.037	1.8K	–+0.00%
15 June 2026	$0.037	$0.037	$0.037	$0.037	864	–+0.00%
12 June 2026	$0.035	$0.037	$0.035	$0.037	34	▲+2.78%
11 June 2026	$0.035	$0.036	$0.035	$0.036	8.5K	▲+2.86%
10 June 2026	$0.035	$0.035	$0.035	$0.035	58	▼-2.78%
9 June 2026	$0.038	$0.038	$0.036	$0.036	3K	–+0.00%
8 June 2026	$0.038	$0.038	$0.034	$0.036	432K	–+0.00%
5 June 2026	$0.038	$0.038	$0.034	$0.036	432K	–+0.00%
4 June 2026	$0.038	$0.038	$0.034	$0.036	432K	▼-5.26%
3 June 2026	$0.038	$0.038	$0.038	$0.038	819	–+0.00%
2 June 2026	$0.038	$0.038	$0.038	$0.038	315	–+0.00%
1 June 2026	$0.04	$0.04	$0.038	$0.038	27K	▼-5.00%
29 May 2026	$0.038	$0.04	$0.038	$0.04	23K	▲+5.26%
28 May 2026	$0.038	$0.038	$0.038	$0.038	8.5K	▲+2.70%
27 May 2026	$0.037	$0.037	$0.037	$0.037	9.3K	–+0.00%
26 May 2026	$0.037	$0.037	$0.037	$0.037	8.7K	▼-2.63%
25 May 2026	$0.038	$0.038	$0.038	$0.038	8.1K	–+0.00%
22 May 2026	$0.038	$0.038	$0.038	$0.038	8K	–+0.00%
21 May 2026	$0.038	$0.038	$0.038	$0.038	8.1K	▼-2.56%
20 May 2026	$0.038	$0.04	$0.038	$0.039	117K	▲+2.63%
19 May 2026	$0.039	$0.039	$0.038	$0.038	31K	–+0.00%
18 May 2026	$0.039	$0.039	$0.038	$0.038	20K	–+0.00%
15 May 2026	$0.038	$0.038	$0.038	$0.038	8.2K	▼-9.52%
14 May 2026	$0.038	$0.042	$0.038	$0.042	28K	▲+10.53%
13 May 2026	$0.036	$0.038	$0.036	$0.038	31K	▲+5.56%
12 May 2026	$0.036	$0.036	$0.036	$0.036	8.1K	–+0.00%
11 May 2026	$0.036	$0.036	$0.036	$0.036	10K	–+0.00%

Argent BioPharma (ASX: RGT) Share Price

RGT

$0.038–+0.00%

$3.2MRank #1761 on ASXHealthcareDrug Manufacturers - Specialty & Generic

Prices updated 20 June 2026, 2:40 am AEST · Data: Financial Modeling Prep

Market Cap

$3.2M

Volume

2.3K

P/E Ratio

-0.39

EPS

-$0.0514

Dividend Yield

0.00%

52-Week High

$0.32

52-Week Low

$0.033

Beta

0.424

Charts

$0.04

24H Range

$0.038

52-Week Range

$0.033

$0.32

About Argent BioPharma Limited

IPO Date

24 Mar 2024

CEO

Roby Reuven Zomer

Website

argentbiopharma.com

Key Financial Data

Revenue (Quarterly)	$115,138
Net Income (Quarterly)	$-3.7M
Total Assets	$2.5M
Total Debt	$8.3M
Free Cash Flow	$-3.3M
Return on Equity	43.01%
Profit Margin	-3223.55%
Operating Margin	-4183.82%

RGT Frequently Asked Questions

What is the Argent BioPharma (ASX: RGT) share price?

The RGT share price is $0.038, up 0.00% for the day, based on the latest available ASX market data.

What is Argent BioPharma's market capitalisation?

Argent BioPharma has a market capitalisation of $3.2M, making it the 1761st-largest security listed on the ASX.

Does Argent BioPharma pay a dividend?

RGT does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Argent BioPharma profitable?

In its most recent reported period (ending 30 June 2025), RGT reported revenue of $115,138 and a net loss of $3.7M.

How many RGT shares are on issue?

Argent BioPharma has approximately 84,969,105 shares on issue, based on its market capitalisation of $3.2M and current share price.

What sector is Argent BioPharma in?

Argent BioPharma is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.

When did Argent BioPharma list on the ASX?

Argent BioPharma listed on the Australian Securities Exchange on 24 Mar 2024.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
ATXAmplia Therapeutics Limited	$59.0M	$0.115	-8.54	0.00%	▼-4.17%
RADRadiopharm Theranostics Limited	$47.3M	$0.02	-0.82	0.00%	–+0.00%
EZZEZZ Life Science Holdings Limited	$24.0M	$0.51	-25.86	1.35%	▲+0.99%
NTINeurotech International Limited	$15.2M	$0.015	-5.30	0.00%	▼-6.25%
PERPercheron Therapeutics Limited	$5.6M	$0.005	-0.79	0.00%	▲+11.11%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$55.71B	$116.32	▼-52.76%
RMDResMed Inc.	$38.70B	$26.68	▼-30.94%
SIGSigma Healthcare Limited	$31.86B	$2.76	▼-13.55%
FPHFisher & Paykel Healthcare Corporation Limited	$18.52B	$31.53	▼-6.24%
PMEPro Medicus Limited	$18.05B	$172.80	▼-38.98%
MPLMedibank Private Limited	$13.36B	$4.85	▲+0.72%
SHLSonic Healthcare Limited	$9.91B	$20.05	▼-23.60%
RHCRamsay Health Care Limited	$9.08B	$39.49	▲+8.93%
COHCochlear Limited	$7.73B	$118.14	▼-60.13%
TLXTelix Pharmaceuticals Limited	$4.91B	$14.50	▼-42.16%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
19 June 2026	$0.038	$0.038	$0.038	$0.038	2.3K	–+0.00%
18 June 2026	$0.035	$0.039	$0.035	$0.038	11K	▲+2.70%
17 June 2026	$0.035	$0.037	$0.035	$0.037	101	–+0.00%
16 June 2026	$0.035	$0.037	$0.035	$0.037	1.8K	–+0.00%
15 June 2026	$0.037	$0.037	$0.037	$0.037	864	–+0.00%
12 June 2026	$0.035	$0.037	$0.035	$0.037	34	▲+2.78%
11 June 2026	$0.035	$0.036	$0.035	$0.036	8.5K	▲+2.86%
10 June 2026	$0.035	$0.035	$0.035	$0.035	58	▼-2.78%
9 June 2026	$0.038	$0.038	$0.036	$0.036	3K	–+0.00%
8 June 2026	$0.038	$0.038	$0.034	$0.036	432K	–+0.00%
5 June 2026	$0.038	$0.038	$0.034	$0.036	432K	–+0.00%
4 June 2026	$0.038	$0.038	$0.034	$0.036	432K	▼-5.26%
3 June 2026	$0.038	$0.038	$0.038	$0.038	819	–+0.00%
2 June 2026	$0.038	$0.038	$0.038	$0.038	315	–+0.00%
1 June 2026	$0.04	$0.04	$0.038	$0.038	27K	▼-5.00%
29 May 2026	$0.038	$0.04	$0.038	$0.04	23K	▲+5.26%
28 May 2026	$0.038	$0.038	$0.038	$0.038	8.5K	▲+2.70%
27 May 2026	$0.037	$0.037	$0.037	$0.037	9.3K	–+0.00%
26 May 2026	$0.037	$0.037	$0.037	$0.037	8.7K	▼-2.63%
25 May 2026	$0.038	$0.038	$0.038	$0.038	8.1K	–+0.00%
22 May 2026	$0.038	$0.038	$0.038	$0.038	8K	–+0.00%
21 May 2026	$0.038	$0.038	$0.038	$0.038	8.1K	▼-2.56%
20 May 2026	$0.038	$0.04	$0.038	$0.039	117K	▲+2.63%
19 May 2026	$0.039	$0.039	$0.038	$0.038	31K	–+0.00%
18 May 2026	$0.039	$0.039	$0.038	$0.038	20K	–+0.00%
15 May 2026	$0.038	$0.038	$0.038	$0.038	8.2K	▼-9.52%
14 May 2026	$0.038	$0.042	$0.038	$0.042	28K	▲+10.53%
13 May 2026	$0.036	$0.038	$0.036	$0.038	31K	▲+5.56%
12 May 2026	$0.036	$0.036	$0.036	$0.036	8.1K	–+0.00%
11 May 2026	$0.036	$0.036	$0.036	$0.036	10K	–+0.00%